Clinical Trial Update: Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on renal denervation using ultrasound for 24-hour blood pressure control in resistant hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: JIMRO Co., Ltd. | Conditions: Hypertension, Vascular Diseases | Phase 3 | Status: COMPLETED